NCT00361790

Aripiprazole and Lexapro Drug Interaction Study

Effects on Aripiprazole on the Steady-State Pharmacokinetics of Escitalopram in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 25 (planned)
• Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

The purpose of this clinical research study is to learn whether aripiprazole has effect on the steady-state pharmacokinetics of escitalopram in healthy subjects. The safety and tolerability of aripiprazole and escitalopram co-administration will also be studied.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Escitalopram on days -7 to day 14; Aripiprazole dosed starting Day 1 to day 14: 3 days at 10 mg, 4 days at 15 mg and 7 days at 20 mg	Tablets, Oral, Escitalopram: 10 mg; Aripiprazole: 10, 15, 20 mg, once daily, 14 days.

Timeline

• Start date: 2006-08-01
• Primary completion: 2006-11-01
• Completion: 2006-11-01
• First posted: 2006-08-09
• Last updated: 2013-11-08

Locations

1 site across 1 country: United States